Vetmedin®

Available in four dosage sizes for cost effectiveness and convenience, VETMEDIN is recommended by the ACVIM as part of standard treatment for dogs with Canine Congestive Heart Failure.1

Important Safety Information: The safe use of VETMEDIN has not been evaluated in dogs younger than 6 months of age, dogs with congenital heart defects, dogs with diabetes mellitus or other serious metabolic diseases, dogs used for breeding, or pregnant or lactating bitches. Use only in dogs with clinical evidence of heart failure. For additional information, see the full prescribing information.

Prozinc®

PROZINC is the only FDA approved protamine zinc insulin for use with diabetic cats, with a convenient duration of 10-14 hours.2

Important Safety Information: The use of any insulin when regulating a diabetic cat may be associated with side effects. The most common side effect reported in field studies was hypoglycemia. This is usually mild (lethargy, weak,trembling, uncoordinated, groggy, dazed), but may be serious and life-threatening (seizures, coma). If side effects occur, cat owners should contact their veterinarian immediately. Hypoglycemia can be fatal if an affected cat does not receive prompt treatment. Please refer to the package insert for complete product information.

Metacam®

Used for over 20 years, METACAM has helped control osteoarthritis pain in dogs in over 30 countries.4 As an oral liquid NSAID for dogs, METACAM Oral Suspension enables accurate and cost-effective titration down to the lowest effective dose.5 And with METACAM Solution for Injection, the first NSAID injection approved for both cats and dogs in the US, timely relief of pain can be given in-office.6

Important Safety Information: As a class, cyclo-oxygenase inhibitory NSAIDs may be associated with gastrointestinal, kidney, or liver side effects. The most common side effects reported in field studies were vomiting and soft stool/diarrhea. These are usually mild, but may be serious. If side effects occur, pet owners should halt therapy and contact their veterinarian. Pets should be evaluated for pre-existing conditions and currently prescribed medications prior to treatment with METACAM, then monitored regularly while on treatment. Concurrent use with another NSAID, corticosteroid, or nephrotoxic medication should be avoided.

The safe use of METACAM Oral Suspension and Solution for Injection in dogs younger than 6 months of age, dogs used for breeding, or in pregnant or lactating dogs has not been evaluated.

The safe use of Metacam 5 mg/mL Solution for Injection in cats younger than 4 months of age, cats used for breeding, or in pregnant or lactating queens has not been evaluated. Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer a second dose of meloxicam. Do not follow meloxicam dose with any other NSAID.

References

1. Atkins C, Bonagura J, Ettinger S, et al. Guidelines for diagnosis and treatment of canine chronic valvular heart disease. J Vet Intern Med. 2009: 23(6): 1142-1150.

2. Nelson RW. Disorders of the Endocrine Pancreas. In: Nelson RW, Couto CG, eds. Small Animal Internal Medicine. 4th ed. St. Louis, MO: Mosby Elsevier; 2008:764-802.

3. Levy, SA. Use of C6ELISA test to evaluate the efficacy of a whole-cell bacterin for the prevention of naturally transmitted canine Borrelia burgdorferi infection. Veterinary Therapeutics. 2002:3(4):420-424.

4. Data on File, Boehringer Ingelheim Vetmedica, Inc.

5. METACAM® (meloxicam) Oral Suspension (for Dogs) [Freedom of Information Summary]. St. Joseph, MO: Boehringer Ingelheim Vetmedica, Inc.; 2003.

6. METACAM® (meloxicam) Solution for Injection [Freedom of Information Summary]. St. Louis, MO: Boehringer Ingelheim Vetmedica, Inc.; 2004.